Eyerising Myopia Management Device
The Eyerising Myopia Management Device uses Repeated Low-Level Red-Light (RLRL) therapy, delivering 650nm visible red light to the back of the eye. This treatment has been shown to improve blood flow and thicken the choroid, which may help address scleral hypoxia linked to myopia progression. The device is supported by more than 40 clinical studies, including two-year trial results showing it can slow myopia progression.
Visit the Eyerising Myopia Management Device website.
Articles on Eyerising Myopia Management Device.
What is repeated low-level red light (RLRL) therapy? Parents’ guide
We explain how repeated low-level red light therapy works to slow myopia progression in children and teenagers, and when they could be a suitable treatment option.
Which is the best option for myopia control?
Explore the proven treatments for myopia control – including glasses, soft contact lenses, orthokeratology, atropine eye drops, and light therapies.